Neurogenesis assay

TS Takahide Shuto
MK Mahomi Kuroiwa
NS Naoki Sotogaku
YK Yukie Kawahara
YO Yong-Seok Oh
JJ Jin-Hyeok Jang
CS Chang-Hoon Shin
YO Yoshinori N. Ohnishi
YH Yuuki Hanada
TM Tsuyoshi Miyakawa
YK Yong Kim
PG Paul Greengard
AN Akinori Nishi
ask Ask a question
Favorite

The neurogenic effect of chronic fluoxetine treatment in combination with D1 receptor agonist/antagonist was assessed as described [22]. Briefly, the mice were labeled with BrdU solution (200 mg/kg) for 2 h prior to sacrifice by perfusion. Preparation of brain sections and immunostaining were done as described above, and stereological quantitation of BrdU-positive cells was performed as described [22]. Briefly, serial coronal sections (40 µm) were cut through the entire hippocampus in its rostrocaudal extension on a cryostat. Every sixth section throughout the hippocampus was processed for BrdU immunohistochemistry. An experimenter blinded to experimental conditions counted all BrdU-labeled cells in the granule cell layer and the SGZ of the dentate gyrus in the total 12 sections from the individual mouse. The total number of BrdU-labeled cells per section was determined and multiplied by 6 to obtain the total number of cells per dentate gyrus.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A